Ben S. Greener

Discovery of Clinical Candidate 4-[2-(5-Amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na_V1.7

Nigel A. Swain, D. V. Batchelor, Serge Beaudoin et al. · Journal of Medicinal Chemistry · 2017 · 83 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Structure–activity relationships of novel non-competitive mGluR1 antagonists: A potential treatment for chronic pain

Dafydd R. Owen, Peter G. Dodd, Simon Gayton et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists

Simon J. Mantell, Karl R. Gibson, Simon A. Osborne et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 17 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9